Lack of association between the P2Y12 receptor gene polymorphism and platelet response to clopidogrel in patients with coronary artery disease. - Wikidata - wikimedia - TriplyDB

Lack of association between the P2Y12 receptor gene polymorphism and platelet response to clopidogrel in patients with coronary artery disease.

Lack of association between the P2Y12 receptor gene polymorphism and platelet response to clopidogrel in patients with coronary artery disease.

http://www.wikidata.org/entity/Q34561115

about

The pharmacogenetic control of antiplatelet response: candidate genes and CYP2C19 Lack of association between gene sequence variations of platelet membrane receptors and aspirin responsiveness detected by the PFA-100 system in patients with coronary artery disease Platelet inhibition with prasugrel (CS-747) compared with clopidogrel in patients undergoing coronary stenting: the subset from the JUMBO study Gene sequence variations of the platelet P2Y12 receptor are associated with coronary artery disease The P2Y 13 Met-158-Thr polymorphism, which is in linkage disequilibrium with the P2Y 12 locus, is not associated with acute myocardial infarction.Associations between P2RY12 gene polymorphisms and risks of clopidogrel resistance and adverse cardiovascular events after PCI in patients with acute coronary syndrome.A case of resistance to clopidogrel and prasugrel after percutaneous coronary angioplasty.Clopidogrel "resistance": where are we now?Personalized approaches to clopidogrel therapy: are we there yet?Historical lessons in translational medicine: cyclooxygenase inhibition and P2Y12 antagonism.P2Y12 polymorphisms and antiplatelet effects of aspirin in patients with coronary artery disease Pharmacogenomics of platelet responsiveness to aspirin.Genetic variation of CYP2C19 affects both pharmacokinetic and pharmacodynamic responses to clopidogrel but not prasugrel in aspirin-treated patients with coronary artery disease.Endobiogeny: a global approach to systems biology (part 1 of 2).Pharmacogenetics of cardiovascular drug therapy.P2Y(12) inhibitors: differences in properties and mechanisms of action and potential consequences for clinical use.Haplotype of platelet receptor P2RY12 gene is associated with residual clopidogrel on-treatment platelet reactivity Clopidogrel pharmacogenomics and risk of inadequate platelet inhibition: US FDA recommendations.Does i-T744C P2Y12 Polymorphism Modulate Clopidogrel Response among Moroccan Acute Coronary Syndromes Patients?Genetic causes of clopidogrel nonresponsiveness: which ones really count?Factors associated with clopidogrel nonresponsiveness.Pharmacogenetics guided anticoagulation.Prasugrel resistance: fact or fiction.The pharmacogenetics of antiplatelet agents: towards personalized therapy?Pharmacogenetics and pharmacogenomics of thienopyridines: clinically relevant?Variability of clopidogrel response in patients with type 2 diabetes mellitus.Recent advances in the pharmacogenetics of clopidogrel.Genetic determinants of response to cardiovascular drugs.Genetic and non-genetic factors affecting the response to clopidogrel therapy.Pharmacokinetic, pharmacodynamic and pharmacogenetic profile of the oral antiplatelet agent ticagrelor.Efficacy of clopidogrel treatment and platelet responsiveness in peripheral arterial procedures.Molecular defects of the platelet P2 receptors.Clinical pharmacokinetics and pharmacodynamics of clopidogrel.Genetically Determined Platelet Reactivity and Related Clinical Implications.Effects of testosterone and 17β-oestradiol on expression of the G protein-coupled receptor P2Y12 in megakaryocytic DAMI cells.A point-of-care assay to measure platelet aggregation in patients taking clopidogrel.Frequency of single nucleotide platelet receptor gene polymorphism (P2Y12-i744T>C) in coronary artery disease patients among Tamilian population.Relationship between clopidogrel-related polymorphisms and variable platelet reactivity at 1 year: A cohort study from Han Chinese.Stroke and aspirin non-responder patients: relation with hypertension and platelet response to adenosine diphosphate.Clopidogrel resistance in North Indian patients of coronary artery disease and lack of its association with platelet ADP receptors P2Y1 and P2Y12 gene polymorphisms.

P2860

Q26801867-BEDFFFFA-8A40-467C-B51B-262504A5416D Q28211198-2B2967AD-D5AF-432B-82CE-73101FA8AC1E Q28218790-350F6042-DD33-4B7B-A720-1906F658755D Q28221103-458507D1-7682-4715-AFB7-7FB6C412BFC1 Q33316014-211CE8A0-98D5-4D65-994B-826762B8628C Q33621348-458C339D-1C56-4F3B-83E7-E37B51907CDA Q34150640-1073773B-03E3-4AB8-AE77-0A8549E63DA3 Q34212563-83A8D7B9-BE64-4BDE-9252-5153AA20583B Q34460548-B084A6A6-9832-4AE0-917C-6659D654819B Q34536091-DA91D432-CCA8-4720-B127-9821864BD5F9 Q36536498-893E926E-1E02-4AB6-84DD-1C8B3E8CAE85 Q36989841-5C4B2758-FDF3-43D6-9E3C-EE38BBF4F0C8 Q37259929-97B14ABC-BB9F-45CD-9A34-06261DD43C61 Q37324095-08C2F7B8-C510-42EA-9D5A-47D87CFF354C Q37430401-B7430BFD-137E-48EF-8390-256D3EF9441B Q37562606-B6DEAC90-FD19-4784-AB85-F7631633EBB4 Q37602843-6D7FA013-26E0-4CCB-B152-684204C51F38 Q37627874-6539E877-8F8F-487F-ADB7-6EE3DC125362 Q37651530-73C9DD7C-B0AB-4D71-977C-AE6E6F65F056 Q37697779-96C37B87-B731-49FB-8AFE-76BFB014BA1D Q37709405-33C15AEF-23D1-402E-B9B6-3CB058C616AC Q37808224-7946729E-15E2-432B-AF51-632B15B1929A Q37905028-E1F85336-E590-45D2-8AB3-EB42784B7C36 Q37913976-6029F514-CC41-42A8-9DF2-09100DE70A26 Q37924323-3F0E6A2F-33A9-4A66-9F3E-351CF703DD08 Q37936014-3099D23C-D1D3-463A-85C7-A4083D36AA3F Q37972231-EEC0475B-D439-43E6-842F-6C232F415069 Q37989811-A7E05421-B0BD-44BA-9201-86FEC42412A0 Q37991382-A69F5B1C-1060-439F-9190-CA33C093B045 Q38001453-5F388EAF-186F-4475-94EB-B97D71319C51 Q38243854-E33E0606-DDD0-4403-B489-06BDEB87F112 Q38306690-3DC2E441-1EDD-465D-8990-A5064913A639 Q38307535-00D8009B-1827-4AC4-A43A-CA9CC5722BBA Q38489014-BB732671-69B0-49E7-A00B-5B8F55E1F903 Q39322667-0B479CA8-1352-42FA-9F99-7B4141A4BB62 Q40329955-DF93EBE1-CFF3-4084-ACBA-16292ECB5048 Q42193725-12DFB39B-82AD-44A3-A9A4-E8A166B10D8B Q42319053-E1F12FBC-F4A8-4198-A5FB-B7DCB792D5E2 Q43255962-80FE7035-C4B8-4B86-8042-00FA2890D1FB Q45190284-B9C89424-F537-4C4C-A7D4-1D94922B58FF

P2860

Lack of association between the P2Y12 receptor gene polymorphism and platelet response to clopidogrel in patients with coronary artery disease.

http://www.wikidata.org/entity/Q34561115

description

2005 nî lūn-bûn

@nan

2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Lack of association between th ...... with coronary artery disease.

@ast

Lack of association between th ...... with coronary artery disease.

@en

Lack of association between th ...... with coronary artery disease.

@nl

type

label

Lack of association between th ...... with coronary artery disease.

@ast

Lack of association between th ...... with coronary artery disease.

@en

Lack of association between th ...... with coronary artery disease.

@nl

prefLabel

Lack of association between th ...... with coronary artery disease.

@ast

Lack of association between th ...... with coronary artery disease.

@en

Lack of association between th ...... with coronary artery disease.

@nl

P1433

Q34561115-F846E969-D7D4-4A08-AB16-9C982BFBB7A3

P1476

Q34561115-0858F84B-9C9D-48D0-982A-257A0E66B365

P2093

Q34561115-039F79F7-1126-4E17-8083-C2B018272042

Q34561115-34B0109F-B631-4711-935A-A3744EA4B1A8

Q34561115-36477064-7FF4-4023-B2C2-335818C24CD5

Q34561115-40C9EE3C-083B-412E-9035-D64076DDD962

Q34561115-49A71AB9-E91B-49C6-BCCE-B6CAB346F857

Q34561115-61B77FC3-79A2-4A18-B660-D852113B18D9

Q34561115-64208E85-E912-4B65-8E15-6DEE43E9BBA1

Q34561115-68218172-F484-4E8A-8E34-00CD00D05156

Q34561115-68F94ABE-E39B-4EFE-B2A8-3B56173F0D1A

Q34561115-6F0EA383-5C8C-4D51-842E-F5C9D542C677

P304

Q34561115-93A8B25F-ABEF-43CE-891D-1CC63A2C17F5

P31

Q34561115-40186C44-825D-4A21-931D-8762DB067032

P356

Q34561115-BC02429D-D7FC-4372-88F9-368F1F77F46A

P433

Q34561115-05E4A828-044D-48FF-AC30-C679940748D5

P478

Q34561115-D842C3B4-A5D9-4821-B0F5-242FA5A79D34

P577

Q34561115-3221E50E-C3B4-4DBD-AD8A-B39B154D4545

P698

Q34561115-61F59664-FA7F-4CA3-AC05-70B3613FF0E1

P921

Q34561115-79514404-6345-4589-AE84-5F1B568EEEEA

Q34561115-E6B1655A-A6CF-49D5-A1E2-6961B79DF594

P356

J.THROMRES.2005.03.001

P1433

Thrombosis Research

P1476

Lack of association between th ...... with coronary artery disease.

@en

P2093

Antonio Fernandez-Ortiz

http://www.w3.org/2001/XMLSchema#string

Camino Bañuelos

http://www.w3.org/2001/XMLSchema#string

Carlos Macaya

http://www.w3.org/2001/XMLSchema#string

Celia Ramírez

http://www.w3.org/2001/XMLSchema#string

Dominick J Angiolillo

http://www.w3.org/2001/XMLSchema#string

Elisabetta Trabetti

http://www.w3.org/2001/XMLSchema#string

Esther Bernardo

http://www.w3.org/2001/XMLSchema#string

Fernando Alfonso

http://www.w3.org/2001/XMLSchema#string

Javier Escaned

http://www.w3.org/2001/XMLSchema#string

Manel Sabaté

http://www.w3.org/2001/XMLSchema#string

P304

491-497

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.THROMRES.2005.03.001

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

116

http://www.w3.org/2001/XMLSchema#string

P577

2005-04-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16181985

http://www.w3.org/2001/XMLSchema#string

P921